Screening of the Positive Inotropic Activity of Medicinal Plants Used in Oriental Medicine |
Choi, Deok-Ho
(Professional Graduate School of Oriental Medicine, Wonkwang University)
Kang, Dae-Gil (Professional Graduate School of Oriental Medicine, Wonkwang University) Kim, Seung-Ju (Professional Graduate School of Oriental Medicine, Wonkwang University) Cui, Xun (Department of Physiology, Yanbian University College of Medicine) Lee, Ho-Sub (Professional Graduate School of Oriental Medicine, Wonkwang University) |
1 | Felker, G.M., O'Connor, C.M. Inotropic therapy for heart failure: an evidence-based approach. American Heart Journal 142, 393-401, 2001 DOI |
2 | Konstam, M.A., Mann, D.L. Contemporary medical options for treating patients with heart failure. Circulation 105, 2244-2246, 2002 DOI ScienceOn |
3 | Simaan, J.A., Faswaz, G., Jabbour, K. Comparison of the cardiodynamic and metabolic effects of dobutamine with those of norepinephrine and dopamine in the isolated heart. Naunyn-Schmiedeberg's Arch Pharmacal 338, 174-179, 1988 |
4 | Schmeller, T., Latz-Bruning, B., Wink, M. Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores. Phytochemistry 44, 257-266, 1997 DOI ScienceOn |
5 | Zeng, X., Zeng, X. Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. Biomedical Chromatography 13(7):442-444, 1999 DOI ScienceOn |
6 | Ko, W.H., Yao, X.O., Lau, C.W., Law, W.I., Chen, Z.Y., Kwok, W., Ho, K., Huang, Y. Vasorelaxant and antiproliferative effect of berberine. European Journal of Pharmacology 399, 187-196, 2000 DOI |
7 | Kimura, M., Thoma, M., Yoshizawa, I. The constituents of Convallaria. VII. Structure of convallagenin-A. Chemical & Pharmaceutical Bulletin 15(8):1204-1211, 1967 DOI ScienceOn |
8 | Wolfgang, K., Brigitte, K., Kurt, J., Helmut, R. Zur biogenese von strophanthidin-glycosiden: Convallatoxol als vorstufe von convallatoxin in Convallaria majalis. Phytochemistry 13, 1805-1808, 1974 DOI ScienceOn |
9 |
Ozaki, H., Nagase, H., Urakawa, N. Interaction of palytoxin and cardiac glycosides on erythrocyte membranes and |
10 | Cho, K.W., Kim, S.H., Kim, C.H., Seul, K.H. Mechanical basis of ANP secretion in beating atria: atrial stroke volume and ECF translocation. American Journal of Physiology 268, 1129-1136, 1995 |
11 | Tang, W., Eisenbrand, G. Chinese crugs of plant origine: chemistry, pharmacology, and used in traditional and modern medicine. Springer-Verlag, Berlin, Germany, pp 361-371, 1992 |
12 | Kimura, M., Thoma, M., Yoshizawa, I. The constituents of Convallaria. II. The isolation of convallasaponin-A, -B, -C. Chemical & Pharmaceutical Bulletin 14(1):50-55, 1966 DOI ScienceOn |
13 | Katz, A. Potential deleterious effect of inotropic agents in the therapy of chronic heart failure. Circulation 73, 184-190, 1986 |
14 | Alpert, N.R., Mulieri, L.A., Warshaw, D. The failing human heart. Cardiovascular Research. 54, 1-10, 2002 DOI ScienceOn |
15 | Guyton, A.C., Hall, J.E. Textbook of medical physiology. 9th Ed., Saunders, Pennsylvania, 107-119, 1996 |
16 | Lau, C.W., Yao, X.Q., Chen, Z.Y., Ko, W.H., Huang, Y. Cardiovascular action of berberine. Cardiovascular Drug Review 19, 234-244, 2001 |
17 | Francis, G.S. Pathophysiology of chronic heart failure. American Journal of Medicine. 110, 37-46, 2001 DOI |
18 | Kimura, M., Thoma, M., Kikuchi, T. The constituents of Convallaria. II. The isolation of desglucocheirotoxin. Japanese Journal of Pharmacology 82, 1320-1323, 1962 |
19 | Katzung, B.G., Parmley, W.W. Cardiac Glycosides & Other Drugs Used in Congestive Heart Failure. 8th Ed., New York, McGraw Hill, 200-218, 2001 |
20 | Sack, R.B., Froehlich, J.L. Berberine inhibits intestinal secretory response of Vibrio chlerae and Escherichia coli enterotoxins. Infection and Immunity 35, 471-475, 1982 |
21 |
Reuter, H., Henderson, S.A., Han, T., Ross, R.S., Goldhaber, J.I., Philipson, K.D. The |
22 | Lehmann, H.D. Effect of plant glycosides on resistance and capacitance vessels. Arzneimittel-Forschung-Drug Research 34(4):423-429, 1984 |
23 | Nishino, H., Kitagawa, K., Fujiki, H., Iwashima, A. Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin. Oncology 43(2):131-134, 1986 DOI |
24 | Chun, Y.T., Yip, T.T., Lau, K.L., Kong, Y.C., Sankawa, U. A biochemical study on the hypotensive effect of berberine in rats. General Pharmacology 10(3), 177-182, 1979 DOI ScienceOn |
25 | Hasenfuss, G., Pieske, B. Calcium cycling in congestive heart failure. Journal of Molecular and Cellular Cardiology 34, 951-969, 2002 DOI ScienceOn |
26 | Lonn, E., Mckelvie, R. Drug treatment in heart failure. British Medical Journal 320, 1188-1192, 2000 DOI |
27 | Braunwald, E., Bristow, M.R. Congestive heart failure: fifty years of progress. Circulation 102, 14-23, 2000 DOI ScienceOn |
28 | Smith, T.W., Artman, E.M., Friedman, P.L., Blatt, C.M., Marsch, J.D. Digitalis glycosides: mechanism and manifestation of toxicity. Progress in Cardiovascular Diseases 26, 495-540, 1984 DOI ScienceOn |
29 | Leier, C.V., Binkley, P.F. Parenteral inotropic support for advanced congestive heart failure. Progress in Cardiovascular Diseases 41(3):207-224, 1998 DOI ScienceOn |
30 | Kang, D.G., Sohn, E.J., Kwon, E.K., Han, J.H., Oh, H., Lee, H.S. Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels. Vascular Pharmacology 39(6):281-286, 2002 DOI ScienceOn |
![]() |